Vanda Pharmaceuticals Inc., a notable biopharmaceutical company, has devoted its resources and expertise to target the highly unmet medical needs of patients worldwide. The company's flagship products, HETLIOZ and Fanapt oral tablets, have become crucial in the treatment of non-24-hour sleep-wake disorders, schizophrenia, and other related disorders. The firm has an extensive pipeline of biomedicines, including HETLIOZ (tasimelteon), which is aimed at treating serious health conditions like insomnia, jet lag disorder, delayed sleep phase disorder, as well as sleep disturbances in autism spectrum disorder, and pediatric Non-24. Fanapt (iloperidone) has been in development not only for the treatment of bipolar I disorder and Parkinson's disease psychosis but also for schizophrenia with a long acting injectable (LAI) formulation. Tradipitant (VLY-686), a neurokinin-1 receptor (NK-1R) antagonist, has shown potential in treating gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia. The company is also developing VTR-297, a small molecule histone deacetylase inhibitor aimed at treating hematologic malignancies, which could hold great promise as a possible oncology treatment. Additionally, they are working on VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist that could impact performance anxiety and psychiatric disorders, VHX-896, an active metabolite of iloperidone, and antisense oligonucleotide molecules. Vanda Pharmaceuticals' cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110, which may hold promise for dry eye and ocular inflammation, and VPO-227 for the treatment of secretory diarrhea disorders such as cholera. Founded in 2002, Vanda Pharmaceuticals is headquartered in Washington, the District of Columbia.
Vanda Pharmaceuticals's ticker is VNDA
The company's shares trade on the NASDAQ stock exchange
They are based in Washington, D.C. United States
There are 51-200 employees working at Vanda Pharmaceuticals
It is vandapharma.com
Vanda Pharmaceuticals is in the Healthcare sector
Vanda Pharmaceuticals is in the Biotechnology industry
The following five companies are Vanda Pharmaceuticals's industry peers: